Earlier this month, Neuralink said tiny wires implanted in the brain of its first patient had pulled out of position. Neuralink expects to implant its device in the second patient in June and a total of 10 people this year, the report said, adding that more than 1,000 quadriplegics had signed up for its patient registry. The FDA said it cannot discuss or disclose information related to any particular company's human trial application or study related to it. The company said in February the first patient implanted with the brain chip was able to control a computer mouse using their thoughts with "no ill effects". The study uses a robot to surgically place a brain-computer interface implant in a region of the brain that controls the intention to move, according to Neuralink.
Source: Wall Street Journal May 20, 2024 13:19 UTC